Novo Nordisk Takes a Hit on China Insulin Price Reductions
Last week, stock prices of two global insulin-manufacturers (Novo Nordisk and Lilly, but Novo Nordisk suffered far more than Lilly did) took a hit on news related to their Chinese operations (seehttps://www.fiercepharma.com/pharma-asia/novo-nordisk-sanofi-eli-lilly-cut-insulin-price-china-s-latest-vbp-off-patent-drugs ANDhttps://endpts.com/china-boasts-48-price-cut-on-insulin-as-domestic-drugmakers-eclipse-big-pharma-in-bulk-order/ for more). Inclusion in China ' s National Reimbursement Drugs List requires volume-based procurement (VBP) discounts. Chinese sales have enabled a number of drug companies to pump-up their sale...
Source: Scott's Web Log - December 6, 2021 Category: Endocrinology Source Type: blogs
Insights From Our New E-book, The Medical Futurist ’s Hype Cycle Of The TOP 50 Digital Health Trends
As a researcher, I have always lived for the moments when I had to see a whole process and analyze the small details at once. Looking into the roots and origins of trends and also seeing the possible outcomes are rewarding in a way that I need to work with data (my passion), my analytical skills and my intuitions.
Besides, I’ve always loved challenging myself in order to be better – that is, for example, why I find my participation in undertakings like the Good Judgement Project (GJP) important.
So when we at The Medical Futurist decided to create a trend analysis of digital health trajectories, we ignited ...
Source: The Medical Futurist - December 2, 2021 Category: Information Technology Authors: Judit Kuszkó Tags: TMF Covid-19 Lifestyle medicine 3D Printing Artificial Intelligence in Medicine Augmented Reality Digital Health Research Future of Medicine Future of Pharma Genomics Health Insurance Health Sensors & Trackers Healthcare Design M Source Type: blogs
Matthew ’s health care tidbits: Drug prices
Each week I’ve been adding a brief tidbits section to the THCB Reader, our weekly newsletter that summarizes the best of THCB that week (Sign up here!). Then I had the brainwave to add them to the blog. They’re short and usually not too sweet! –Matthew Holt
For my health care tidbits this week, I am going to talk drug pricing. Anyone who gets basically any health policy newsletter has seen some of the cash PhRMA has splashed trying to make it seem as though the American public is terrified of drug price controls. But as Michael Millenson on a recent THCB Gang pointed out, when Kaiser Health News asked the questio...
Source: The Health Care Blog - November 30, 2021 Category: Consumer Health News Authors: matthew holt Tags: Health Policy Matthew Holt Pharmaceuticals Drug Pricing KHN Source Type: blogs
Machine Learning in Pharma: Mindbreeze InSpire
Where are pharma companies investing their windfall profits? The companies are evolving in many ways, including stepping outside drug development to tryout digital treatments and using lessons from the COVID-19 pandemic to rethink production and clinical trials. I spoke recently to Daniel Fallmann, founder and CEO of Mindbreeze, about what pharma companies are doing with […] (Source: EMR and HIPAA)
Source: EMR and HIPAA - November 24, 2021 Category: Information Technology Authors: Andy Oram Tags: AI/Machine Learning Analytics/Big Data Health IT Company Healthcare IT Clinical Trial Recruitment Clinical Trials Daniel Fallmann Data Mining Dell Dell Healthcare Healthcare AI Healthcare Machine Learning Mindbreeze InSpire NVDIA Source Type: blogs
Medicine Packaging And Augmented Reality: A Missed Opportunity For Pharma Companies
Augmented reality offers umpteen possibilities in healthcare – we just recently wrote about 9 great use cases of it in an article. But there’s one area we did not touch there for a reason: medicine packaging. This unorthodox approach to product communication could be one of the easiest ways to enhance patient satisfaction, educate and help people and, at the same time increase customer loyalty. And with the widening number of smartphone applications actually using this technology, it is getting more affordable by the day.
So why are pharmaceutical companies missing out on this excellent resource?
Related:
Aug...
Source: The Medical Futurist - November 18, 2021 Category: Information Technology Authors: Judit Kuszkó Tags: Artificial Intelligence in Medicine Future of Medicine Future of Pharma Medical Education Personalized Medicine Telemedicine & Smartphones augmented reality design digital technology pharmaceutics packaging Source Type: blogs
